Wellness Market News: Herbal Product Sales Jump; FTC Expects $6M From 'Free Trial' Supplement Marketers
Executive Summary
US herbal supplement sales' growth in 2018 was strongest since 1998, says American Botanical Council's Herb Market Report; and principals of Apex Capital Group and 12 businesses they controlled agree to orders settling FTC's allegations.
You may also be interested in...
'Free Trial' Plus False Claims Equals More FTC Enforcement In Supplement Market
FTC on consecutive days announced court order closing a California business allegedly charging consumers for products and enrolling them in negative-option continuity plans without their consent after they responded to bogus free trial online offers, and started mailing 16,596 checks totaling more than $750,000 to consumers who bought deceptively marketed supplements from a Maine firm that also lured customers with a free trial pitch.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.